MetaMask's upcoming rewards program will distribute $30 million in LINEA during first season
Quick Take MetaMask revealed details of its upcoming rewards program on X Saturday, saying it will be “one of the largest onchain rewards programs ever built,” and teasing over $30 million in LINEA rewards during its first “season.” The rewards will have “meaningful connections” to the forthcoming MetaMask token, according to the popular wallet app’s team. Linea is an Ethereum Layer 2 network incubated by Consensys, which created MetaMask. The full program will be rolled out within the next couple of weeks
MetaMask, the popular Web3 wallet created by Consensys, will roll out an onchain rewards program "in the next couple of weeks," MetaMask announced on X Saturday.
The program "will yield referral rewards, mUSD incentives, exclusive partner rewards, access to tokens, and more," MetaMask said , and will distribute "over $30M in LINEA token rewards" during its first season. LINEA is the native token of Linea, an Ethereum Layer 2 network also incubated by Consensys, and was launched in September with a 9.4 billion token airdrop.
"Long-time MetaMask users will not be ignored - they'll be given special benefits, and MetaMask Rewards will have meaningful connections with the future MetaMask token," MetaMask wrote in its announcement. MetaMask also said the program is "not a farming play" and represents "a genuine method of regularly giving back to our community."
It is unclear whether users in certain jurisdictions will be restricted from participating in the program, and if any anti-Sybil measures will be enacted by MetaMask. The Block could not immediately reach MetaMask for comment.
MetaMask's planned MASK token was announced by Ethereum co-founder and Consensys CEO Joseph Lubin in mid-September. Lubin said, on The Block's "The Crypto Beat" podcast, that the MASK token "is significantly related to the decentralization of certain aspects of the MetaMask platform."
MetaMask's mUSD stablecoin went live around the same time, issued by Stripe-owned firm Bridge. The token currently has a circulating supply of $87.7 million, according to the token's website , The token was launched on Ethereum and Linea, and is not yield-bearing.
MetaMask's announcement was met with criticism by some X users. "[T]his will go over well and no one will be disgusted and insult you," crypto streamer "Gainzy" wrote in one sarcastic response.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
U.S. non-farm payrolls surge by 165,000 in October, far exceeding expectations! Unemployment rate unexpectedly drops to 4.1%, December rate hike expectations intensify
In October, US non-farm payrolls increased by 165,000, which is 2.5 times the Wall Street median forecast of 65,000 and represents an exceptionally strong deviation of about 5 standard deviations, exceeding the upper limit of all institutional forecast ranges. The unemployment rate unexpectedly fell from 4.2% to 4.1%, while the market had expected it to remain unchanged; average hourly wages also accelerated year-on-year growth to 3.1%. Meanwhile, the previous two months' non-farm payrolls were revised upwards by a total of 84,000. Following the release of the data, the yield on 2-year US Treasury bonds rose by 7 basis points, and the pricing of the probability of a Fed rate hike in December climbed to 70%.
AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion
The valuation range discussed by potential investors has been lowered from the previous high of $2 trillion to between $1.2 trillion and $1.3 trillion, and some strategists have even suggested going below $1 trillion to ensure safety. In the face of significant market volatility and financial concerns such as quarterly losses, Anthropic is facing tough decisions, including a discounted valuation, reducing the size of the offering, or postponing the listing.

Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight
Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.
